Compounds > zalcitabine
Page last updated: 2024-08-22

zalcitabine and Atrophy

zalcitabine has been researched along with Atrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collins, BJ; Dunnick, JK; Elwell, MR; Heath, JE; Irwin, RD; Lindamood, C; Prejean, D; Rao, GN; Sanders, VM1
Buckley, LA; Collins, BJ; Foley, JF; Giles, HD; Heath, JE; May, RD; Rao, GN1

Other Studies

2 other study(ies) available for zalcitabine and Atrophy

ArticleYear
Induction of thymic lymphoma in mice administered the dideoxynucleoside ddC.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1995, Volume: 27, Issue:2

    Topics: Animals; Antiviral Agents; Atrophy; Body Weight; Female; Intubation, Gastrointestinal; Lymphoma; Male; Mice; Mice, Inbred Strains; Organ Size; Thymus Gland; Thymus Neoplasms; Zalcitabine

1995
Carcinogenicity of 2',3'-dideoxycytidine in mice.
    Cancer research, 1996, Oct-15, Volume: 56, Issue:20

    Topics: Anemia; Animals; Anti-HIV Agents; Atrophy; Body Weight; Carcinogenicity Tests; CD4-CD8 Ratio; Female; Lymphoma, T-Cell; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Sex Factors; Species Specificity; Thymus Gland; Thymus Neoplasms; Time Factors; Tumor Suppressor Protein p53; Zalcitabine

1996